The Role of NCOA4-Mediated in

[1]  Stephen A. Sastra,et al.  Cysteine depletion induces pancreatic tumor ferroptosis in mice , 2020, Science.

[2]  A. Chinnaiyan,et al.  Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. , 2019, Cancer discovery.

[3]  S. Dixon,et al.  Prominin2 Drives Ferroptosis Resistance by Stimulating Iron Export. , 2019, Developmental cell.

[4]  Qiang Liu,et al.  The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin , 2019, Cell biology international.

[5]  Edward W. Tate,et al.  FSP1 is a glutathione-independent ferroptosis suppressor , 2019, Nature.

[6]  J. Olzmann,et al.  The CoQ oxidoreductase FSP1 acts in parallel to GPX4 to inhibit ferroptosis , 2019, Nature.

[7]  M. Ferrari,et al.  Stem Cell Modeling of Neuroferritinopathy Reveals Iron as a Determinant of Senescence and Ferroptosis during Neuronal Aging , 2019, Stem cell reports.

[8]  G. Latunde-Dada,et al.  Programmed Cell-Death by Ferroptosis: Antioxidants as Mitigators , 2019, International journal of molecular sciences.

[9]  B. Stockwell,et al.  Intercellular interaction dictates cancer cell ferroptosis via NF2–YAP signalling , 2019, Nature.

[10]  J. Chi,et al.  Kinome screen of ferroptosis reveals a novel role of ATM in regulating iron metabolism , 2019, Cell Death & Differentiation.

[11]  T. Iwamoto,et al.  Involvement of cigarette smoke-induced epithelial cell ferroptosis in COPD pathogenesis , 2019, Nature Communications.

[12]  T. Vanden Berghe,et al.  Targeting Ferroptosis to Iron Out Cancer. , 2019, Cancer cell.

[13]  J. Pouysségur,et al.  Genetic ablation of the cystine transporter xCT in PDAC cells inhibits mTORC1, growth, survival and tumor formation via nutrient and oxidative stresses. , 2019, Cancer research.

[14]  Xuejun Jiang,et al.  Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis , 2019, Cell Death & Differentiation.

[15]  B. Stockwell,et al.  Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model. , 2019, Cell chemical biology.

[16]  A. Chinnaiyan,et al.  CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy , 2019, Nature.

[17]  John G Doench,et al.  A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis , 2019, Nature Communications.

[18]  P. Wipf,et al.  Ferroptosis as a Novel Therapeutic Target for Friedreich’s Ataxia , 2019, The Journal of Pharmacology and Experimental Therapeutics.

[19]  B. Li,et al.  Ferroptosis, a new form of cell death: opportunities and challenges in cancer , 2019, Journal of Hematology & Oncology.

[20]  B. Stockwell,et al.  The Hallmarks of Ferroptosis , 2019, Annual Review of Cancer Biology.

[21]  Yong Hu,et al.  Deferoxamine promotes recovery of traumatic spinal cord injury by inhibiting ferroptosis , 2019, Neural regeneration research.

[22]  A. Atri.  The Alzheimer's Disease Clinical Spectrum: Diagnosis and Management. , 2019, The Medical clinics of North America.

[23]  Changlian Zhu,et al.  The Potential Role of Ferroptosis in Neonatal Brain Injury , 2019, Front. Neurosci..

[24]  M. Fleming,et al.  NCOA4 maintains murine erythropoiesis via cell autonomous and non-autonomous mechanisms , 2019, Haematologica.

[25]  Jia-Yi Li,et al.  Lactoferrin ameliorates dopaminergic neurodegeneration and motor deficits in MPTP-treated mice , 2018, Redox biology.

[26]  J. Mancias,et al.  The Role of NCOA4-Mediated Ferritinophagy in Health and Disease , 2018, Pharmaceuticals.

[27]  Feng Zhang,et al.  Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells , 2018, Autophagy.

[28]  G. Verdile,et al.  Dysregulation of Neuronal Iron Homeostasis as an Alternative Unifying Effect of Mutations Causing Familial Alzheimer’s Disease , 2018, Front. Neurosci..

[29]  A. Brech,et al.  Starvation induces rapid degradation of selective autophagy receptors by endosomal microautophagy , 2018, The Journal of cell biology.

[30]  T. Malm,et al.  Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration , 2018, Front. Neurosci..

[31]  T. Vanden Berghe,et al.  Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma , 2018, The Journal of clinical investigation.

[32]  Wei‐Chao Chang,et al.  Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis. , 2018, Cancer letters.

[33]  L. Defebvre,et al.  Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis? , 2017, Antioxidants & redox signaling.

[34]  Idhaliz Flores,et al.  Expression and function of nuclear receptor coactivator 4 isoforms in transformed endometriotic and malignant ovarian cells , 2017, Oncotarget.

[35]  A. Walch,et al.  Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis , 2017, Cell.

[36]  Zhan-You Wang,et al.  α-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice , 2017, Redox biology.

[37]  A. Gianoncelli,et al.  Expression and characterization of the ferritin binding domain of Nuclear Receptor Coactivator-4 (NCOA4). , 2017, Biochimica et biophysica acta. General subjects.

[38]  D. Sabatini,et al.  NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis , 2017, Nature.

[39]  B. Stockwell,et al.  Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease , 2017, Cell.

[40]  A. Bush,et al.  Tau-mediated iron export prevents ferroptotic damage after ischemic stroke , 2017, Molecular Psychiatry.

[41]  R. Xavier,et al.  Autophagy-Independent Lysosomal Targeting Regulated by ULK1/2-FIP200 and ATG9. , 2017, Cell reports.

[42]  A. Bush,et al.  Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis , 2017, Redox biology.

[43]  M. Rauh,et al.  Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis , 2017, Oncogenesis.

[44]  Jill P. Mesirov,et al.  Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway , 2017, Nature.

[45]  Stuart L. Schreiber,et al.  Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition , 2017, Nature.

[46]  P. Shaw,et al.  The role of mitochondria in amyotrophic lateral sclerosis , 2017, Neuroscience Letters.

[47]  M. Bauer,et al.  Metabolic Adaptation Establishes Disease Tolerance to Sepsis , 2017, Cell.

[48]  S. Hersch,et al.  KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients , 2017, Proceedings of the National Academy of Sciences.

[49]  Qian Wu,et al.  Supporting Information Characterization of Ferroptosis in Murine Models of Hemochromatosis , 2017 .

[50]  Maneesh C. Patel,et al.  Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson’s disease , 2017, Scientific Reports.

[51]  C. Philpott,et al.  PCBP1 and NCOA4 regulate erythroid iron storage and heme biosynthesis , 2017, The Journal of clinical investigation.

[52]  B. Stockwell,et al.  Inhibition of neuronal ferroptosis protects hemorrhagic brain. , 2017, JCI insight.

[53]  G. Ning,et al.  Iron addiction: A novel therapeutic target in ovarian cancer , 2017, Oncogene.

[54]  J. Mancias,et al.  The Role of Autophagy in Cancer. , 2017, Annual review of cancer biology.

[55]  Blaine R. Roberts,et al.  Glutathione peroxidase 4: a new player in neurodegeneration? , 2017, Molecular Psychiatry.

[56]  Qitao Ran,et al.  Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration , 2017, Redox biology.

[57]  S. Rivella,et al.  A Red Carpet for Iron Metabolism , 2017, Cell.

[58]  Dennis W Dickson,et al.  Pathology of Neurodegenerative Diseases. , 2017, Cold Spring Harbor perspectives in biology.

[59]  J. Roh,et al.  Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis , 2016, Redox biology.

[60]  A. F. Gietl,et al.  Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment , 2016, Scientific Reports.

[61]  R. Bordet,et al.  Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC , 2016, Neurobiology of Disease.

[62]  Q. Pan,et al.  Ferroptosis is an autophagic cell death process , 2016, Cell Research.

[63]  B. Stockwell,et al.  Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis , 2016, Proceedings of the National Academy of Sciences.

[64]  K. Blennow,et al.  Alzheimer's disease , 2016, The Lancet.

[65]  M. Lotze,et al.  Autophagy promotes ferroptosis by degradation of ferritin , 2016, Autophagy.

[66]  A. Newberg,et al.  N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data , 2016, PloS one.

[67]  J. Mancias,et al.  Mechanisms of Selective Autophagy in Normal Physiology and Cancer. , 2016, Journal of molecular biology.

[68]  Makoto Yaegashi,et al.  An essential role for functional lysosomes in ferroptosis of cancer cells. , 2016, The Biochemical journal.

[69]  Y. Tsuji,et al.  Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease. , 2016, Trends in biochemical sciences.

[70]  B. Stockwell,et al.  Ferroptosis: Death by Lipid Peroxidation. , 2016, Trends in cell biology.

[71]  E. White,et al.  Atg7 cooperates with Pten loss to drive prostate cancer tumor growth , 2016, Genes & development.

[72]  M. Santoro,et al.  NCOA4 Deficiency Impairs Systemic Iron Homeostasis. , 2016, Cell reports.

[73]  D. Tang,et al.  Ferroptosis: process and function , 2016, Cell Death and Differentiation.

[74]  D. Tang,et al.  Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells , 2016, Hepatology.

[75]  Randall J. Platt,et al.  Thyroid hormone receptor beta and NCOA4 regulate terminal erythrocyte differentiation , 2017, Proceedings of the National Academy of Sciences.

[76]  Qitao Ran,et al.  Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and Paralysis* , 2015, The Journal of Biological Chemistry.

[77]  A. Lang,et al.  Parkinson's disease , 2015, The Lancet.

[78]  W. Goessling,et al.  Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis , 2015, eLife.

[79]  Alzheimer’s Disease Neuroimaging Initiative,et al.  Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE , 2015 .

[80]  C. Camaschella.  Iron-deficiency anemia. , 2015, The New England journal of medicine.

[81]  Carmela Fimognari,et al.  Broad targeting of resistance to apoptosis in cancer , 2015, Seminars in cancer biology.

[82]  E. White,et al.  Atg7 Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma. , 2015, Cancer discovery.

[83]  Haichao Wang,et al.  HSPB1 as a Novel Regulator of Ferroptotic Cancer Cell Death , 2015, Oncogene.

[84]  A. Walch,et al.  Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice , 2014, Nature Cell Biology.

[85]  John A. Tallarico,et al.  Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo , 2014, Nature Cell Biology.

[86]  B. Leavitt,et al.  Iron dysregulation in Huntington's disease , 2014, Journal of neurochemistry.

[87]  M. Santoro,et al.  NCOA4 transcriptional coactivator inhibits activation of DNA replication origins. , 2014, Molecular cell.

[88]  G. Bloom.  Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. , 2014, JAMA neurology.

[89]  S. Gygi,et al.  Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy , 2014, Nature.

[90]  B. Stockwell,et al.  Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models , 2014, Journal of the American Chemical Society.

[91]  Matthew E. Welsch,et al.  Regulation of Ferroptotic Cancer Cell Death by GPX4 , 2014, Cell.

[92]  S. Hersch,et al.  Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine , 2013, PloS one.

[93]  V. Karantza,et al.  Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer. , 2013, Cancer discovery.

[94]  N. Matsumoto,et al.  De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood , 2013, Nature Genetics.

[95]  Pu Wang,et al.  Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain , 2013, Neurochemistry International.

[96]  A. Tartakoff,et al.  Mechanisms of mammalian iron homeostasis. , 2012, Biochemistry.

[97]  M. R. Lamprecht,et al.  Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.

[98]  R. Camp,et al.  Punctate LC3B Expression Is a Common Feature of Solid Tumors and Associated with Proliferation, Metastasis, and Poor Outcome , 2011, Clinical Cancer Research.

[99]  Baljit Singh,et al.  Distinct function of androgen receptor coactivator ARA70α and ARA70β in mammary gland development, and in breast cancer , 2011, Breast Cancer Research and Treatment.

[100]  Marc Liesa,et al.  Pancreatic cancers require autophagy for tumor growth. , 2011, Genes & development.

[101]  A. McKee,et al.  Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington’s disease mice , 2011, Acta Neuropathologica.

[102]  F. Ishikawa,et al.  Distinct Mechanisms of Ferritin Delivery to Lysosomes in Iron-Depleted and Iron-Replete Cells , 2011, Molecular and Cellular Biology.

[103]  H. Coller,et al.  Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. , 2011, Genes & development.

[104]  A. Manning-Boğ,et al.  Glutathione Peroxidase 4 is associated with Neuromelanin in Substantia Nigra and Dystrophic Axons in Putamen of Parkinson's brain , 2011, Molecular Neurodegeneration.

[105]  C. Kenific,et al.  Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation , 2011, Molecular biology of the cell.

[106]  Wei Li,et al.  Lysosomal proteolysis is the primary degradation pathway for cytosolic ferritin and cytosolic ferritin degradation is necessary for iron exit. , 2010, Antioxidants & redox signaling.

[107]  M. Willingham,et al.  Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis , 2010, Science Translational Medicine.

[108]  Sandra Barth,et al.  Autophagy: cellular and molecular mechanisms , 2010, The Journal of pathology.

[109]  Mario Amendola,et al.  Oxidative stress and cell death in cells expressing L-ferritin variants causing neuroferritinopathy , 2010, Neurobiology of Disease.

[110]  Charles Duyckaerts,et al.  Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease , 2008, Proceedings of the National Academy of Sciences.

[111]  K. Blennow,et al.  Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial , 2008, The Lancet Neurology.

[112]  B. Stockwell,et al.  Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. , 2008, Chemistry & biology.

[113]  T. Babić,et al.  Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington’s disease gene carriers and healthy subjects , 2007, Journal of Neurology.

[114]  K. Hall,et al.  Selenium level and cognitive function in rural elderly Chinese. , 2007, American journal of epidemiology.

[115]  G. Musci,et al.  Ferroportin‐mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome , 2006, The EMBO journal.

[116]  R. Cousins,et al.  Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells , 2006, Proceedings of the National Academy of Sciences.

[117]  M. Linder,et al.  Release of iron from ferritin requires lysosomal activity. , 2006, American journal of physiology. Cell physiology.

[118]  H. Howie,et al.  Neisseria meningitidis accelerates ferritin degradation in host epithelial cells to yield an essential iron source , 2004, Molecular microbiology.

[119]  M. Büchler,et al.  Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas. , 2004, European journal of cancer.

[120]  T. Montine,et al.  Lipid peroxidation in aging brain and Alzheimer's disease. , 2002, Free radical biology & medicine.

[121]  U. Brunk,et al.  -Lipoic acid and -lipoamide prevent oxidant-induced lysosomal rupture and apoptosis , 2001 .

[122]  Y. Gruenbaum,et al.  Repression of ferritin expression modulates cell responsiveness to H-ras-induced growth. , 2001, Biochemical Society transactions.

[123]  T. Brown,et al.  Activation of androgen receptor-associated protein 70 (ARA70) mRNA expression in ovarian cancer. , 2001, Gynecologic oncology.

[124]  Kou-Juey Wu,et al.  Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. , 1999, Science.

[125]  M. Beal,et al.  Oxidative Stress in Huntington's Disease , 1999, Brain pathology.

[126]  D. Radisky,et al.  Iron in cytosolic ferritin can be recycled through lysosomal degradation in human fibroblasts. , 1998, The Biochemical journal.

[127]  M. Mattson,et al.  Protein modification by the lipid peroxidation product 4‐hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients , 1998, Annals of neurology.

[128]  K. Öllinger,et al.  Nutrient Deprivation of Cultured Rat Hepatocytes Increases the Desferrioxamine-available Iron Pool and Augments the Sensitivity to Hydrogen Peroxide* , 1997, The Journal of Biological Chemistry.

[129]  S. Daniel,et al.  Glutathione‐related enzymes in brain in Parkinson's disease , 1994, Annals of neurology.

[130]  C. Marsden,et al.  Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease , 1989, Journal of neurochemistry.

[131]  Yuanrong Cheng,et al.  Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[132]  M. Hayden,et al.  Huntington disease , 2015, Nature Reviews Disease Primers.

[133]  R. Brigelius-Flohé,et al.  Glutathione peroxidases. , 2013, Biochimica et biophysica acta.

[134]  F. LaFerla,et al.  Alzheimer's disease. , 2010, The New England journal of medicine.

[135]  W. Gerald,et al.  Stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70. , 2008, The American journal of pathology.

[136]  G. Münch,et al.  α-Lipoic acid as a new treatment option for Alzheimer’s disease — a 48 months follow-up analysis , 2007 .

[137]  D. Richardson,et al.  Examination of the mechanism(s) involved in doxorubicin-mediated iron accumulation in ferritin: studies using metabolic inhibitors, protein synthesis inhibitors, and lysosomotropic agents. , 2004, Molecular pharmacology.

[138]  C. Marsden,et al.  Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study , 1994, Movement disorders : official journal of the Movement Disorder Society.

[139]  H. Fenton,et al.  LXXIII.—Oxidation of tartaric acid in presence of iron , 1894 .